Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trialDemetris Yannopoulos, Tom P. Aufderheide, John E. Connett et al.|The Lancet|2020Cited by 1k
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialThomas L Holland, Robert C. Hyzy, Adit A. Ginde et al.|The Lancet Respiratory Medicine|2022Cited by 127